Cargando…

Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression

Hypoxia-inducible factor-1α (HIF-1α) mediates the response to hypoxia or other stimuli, such as growth factors, including endothelin-1 (ET-1), to promote malignant progression in numerous tumors. The importance of cofactors that regulate HIF-1α signalling within tumor is not well understood. Here we...

Descripción completa

Detalles Bibliográficos
Autores principales: Cianfrocca, Roberta, Tocci, Piera, Rosanò, Laura, Caprara, Valentina, Sestito, Rosanna, Di Castro, Valeriana, Bagnato, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951250/
https://www.ncbi.nlm.nih.gov/pubmed/26909598
http://dx.doi.org/10.18632/oncotarget.7461
_version_ 1782443668059193344
author Cianfrocca, Roberta
Tocci, Piera
Rosanò, Laura
Caprara, Valentina
Sestito, Rosanna
Di Castro, Valeriana
Bagnato, Anna
author_facet Cianfrocca, Roberta
Tocci, Piera
Rosanò, Laura
Caprara, Valentina
Sestito, Rosanna
Di Castro, Valeriana
Bagnato, Anna
author_sort Cianfrocca, Roberta
collection PubMed
description Hypoxia-inducible factor-1α (HIF-1α) mediates the response to hypoxia or other stimuli, such as growth factors, including endothelin-1 (ET-1), to promote malignant progression in numerous tumors. The importance of cofactors that regulate HIF-1α signalling within tumor is not well understood. Here we elucidate that ET-1/ET(A) receptor (ET(A)R)-induced pathway physically and functionally couples the scaffold protein β-arrestin1 (β-arr1) to HIF-1α signalling. In epithelial ovarian cancer (EOC) cells, ET-1/ET(A)R axis induced vascular-endothelial growth factor (VEGF) expression through HIF-1α nuclear accumulation. In these cells, activation of ET(A)R by ET-1, by mimicking hypoxia, promoted the nuclear interaction between β-arr1 and HIF-1α and the recruitment of p300 acetyltransferase to hypoxia response elements on the target gene promoters, resulting in enhanced histone acetylation, and HIF-1α target gene transcription. Indeed, β-arr1-HIF-1α interaction regulated the enhanced expression and release of downstream targets, such as ET-1 and VEGF, required for tumor cell invasion and pro-angiogenic effects in endothelial cells. These effects were abrogated by β-arr1 or HIF-1α silencing or by pharmacological treatment with the dual ET-1 receptor antagonist macitentan. Interestingly, ET(A)R/β-arr1 promoted the self-amplifying HIF-1α-mediated transcription of ET-1 that sustained a regulatory circuit involved in invasive and angiogenic behaviors. In a murine orthotopic model of metastatic human EOC, treatment with macitentan, or silencing of β-arr1, inhibits intravasation and metastasis formation. Collectively, these findings reveal the interplay of β-arr1 with HIF-1α in the complexity of ET-1/ET(A)R signalling, mediating epigenetic modifications directly involved in the metastatic process, and suggest that targeting ET-1-dependent β-arr1/HIF-1α pathway by using macitentan may impair EOC progression.
format Online
Article
Text
id pubmed-4951250
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-49512502016-07-21 Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression Cianfrocca, Roberta Tocci, Piera Rosanò, Laura Caprara, Valentina Sestito, Rosanna Di Castro, Valeriana Bagnato, Anna Oncotarget Research Paper Hypoxia-inducible factor-1α (HIF-1α) mediates the response to hypoxia or other stimuli, such as growth factors, including endothelin-1 (ET-1), to promote malignant progression in numerous tumors. The importance of cofactors that regulate HIF-1α signalling within tumor is not well understood. Here we elucidate that ET-1/ET(A) receptor (ET(A)R)-induced pathway physically and functionally couples the scaffold protein β-arrestin1 (β-arr1) to HIF-1α signalling. In epithelial ovarian cancer (EOC) cells, ET-1/ET(A)R axis induced vascular-endothelial growth factor (VEGF) expression through HIF-1α nuclear accumulation. In these cells, activation of ET(A)R by ET-1, by mimicking hypoxia, promoted the nuclear interaction between β-arr1 and HIF-1α and the recruitment of p300 acetyltransferase to hypoxia response elements on the target gene promoters, resulting in enhanced histone acetylation, and HIF-1α target gene transcription. Indeed, β-arr1-HIF-1α interaction regulated the enhanced expression and release of downstream targets, such as ET-1 and VEGF, required for tumor cell invasion and pro-angiogenic effects in endothelial cells. These effects were abrogated by β-arr1 or HIF-1α silencing or by pharmacological treatment with the dual ET-1 receptor antagonist macitentan. Interestingly, ET(A)R/β-arr1 promoted the self-amplifying HIF-1α-mediated transcription of ET-1 that sustained a regulatory circuit involved in invasive and angiogenic behaviors. In a murine orthotopic model of metastatic human EOC, treatment with macitentan, or silencing of β-arr1, inhibits intravasation and metastasis formation. Collectively, these findings reveal the interplay of β-arr1 with HIF-1α in the complexity of ET-1/ET(A)R signalling, mediating epigenetic modifications directly involved in the metastatic process, and suggest that targeting ET-1-dependent β-arr1/HIF-1α pathway by using macitentan may impair EOC progression. Impact Journals LLC 2016-02-17 /pmc/articles/PMC4951250/ /pubmed/26909598 http://dx.doi.org/10.18632/oncotarget.7461 Text en Copyright: © 2016 Cianfrocca et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Cianfrocca, Roberta
Tocci, Piera
Rosanò, Laura
Caprara, Valentina
Sestito, Rosanna
Di Castro, Valeriana
Bagnato, Anna
Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression
title Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression
title_full Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression
title_fullStr Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression
title_full_unstemmed Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression
title_short Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression
title_sort nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951250/
https://www.ncbi.nlm.nih.gov/pubmed/26909598
http://dx.doi.org/10.18632/oncotarget.7461
work_keys_str_mv AT cianfroccaroberta nuclearbarrestin1isacriticalcofactorofhypoxiainduciblefactor1asignalinginendothelin1inducedovariantumorprogression
AT toccipiera nuclearbarrestin1isacriticalcofactorofhypoxiainduciblefactor1asignalinginendothelin1inducedovariantumorprogression
AT rosanolaura nuclearbarrestin1isacriticalcofactorofhypoxiainduciblefactor1asignalinginendothelin1inducedovariantumorprogression
AT capraravalentina nuclearbarrestin1isacriticalcofactorofhypoxiainduciblefactor1asignalinginendothelin1inducedovariantumorprogression
AT sestitorosanna nuclearbarrestin1isacriticalcofactorofhypoxiainduciblefactor1asignalinginendothelin1inducedovariantumorprogression
AT dicastrovaleriana nuclearbarrestin1isacriticalcofactorofhypoxiainduciblefactor1asignalinginendothelin1inducedovariantumorprogression
AT bagnatoanna nuclearbarrestin1isacriticalcofactorofhypoxiainduciblefactor1asignalinginendothelin1inducedovariantumorprogression